Eli Lilly's 70% price drop on insulin is the ‘tip of the iceberg' in fight to lower drug costs, Northeastern expert says
Gary Young, director of Northeastern University's Center for Health Policy and Healthcare Research, professor of strategic management and healthcare systems, says insulin has become “a lightning rod” for concerns about rising drug costs. But Eli Lilly's decision is only the latest move in the fight to lower drug costs.